The MT1-MMP antibody DX-2400, when applied in the 4T1 triple-negative breast cancer mouse model, inhibited tumor growth, shifted macrophages towards the antitumor M1-like phenotype, and reduced activated TGFβ (an immunosuppressive cytokine) [102]. Here, MMP14 is linked to neoplasm.